Clinical Trials Browser

Phase 1 × Hematologic Neoplasms × R-CHOP protocol × Clear all

NCT04243434 2020-04-16

PK Study on Ready-to-Use Injection (VSLI-RTU) 1 Vial & 3 Vial Formulation Marqibo® in Hematological Malignant Patients

Phase 1 Unknown

Other hematologic neoplasm

Hematologic Diseases, Hematologic Neoplasms